13F Data
13F filer · CIK 1335325

HighVista Strategies LLC

BOSTON, MA · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$438.6M
+$76.4M vs prior
Positions
147
New / sold out
29 / 38
Added / reduced
50 / 66
Turnover
24.2%
buys $99.1M · sells $96.9M
Top-10 weight
28.2%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewC4 THERAPEUTICS INC+1,348,136–+$6.3M
AddedALKERMES PLC+106,067+144.9%+$5.6M
AddedTANGO THERAPEUTICS INC+155,877+149.6%+$4.9M
AddedENLIVEN THERAPEUTICS INC+64,764+88.6%+$3.3M
NewRELMADA THERAPEUTICS INC+445,799–+$3.1M
AddedTRAVERE THERAPEUTICS INC+49,908+137.4%+$2.8M
AddedDEFINIUM THERAPEUTICS INC+57,028+30.7%+$2.7M
AddedALUMIS INC+87,039+77.1%+$2.4M
AddedTARSUS PHARMACEUTICALS INC+34,596+65.9%+$2.2M
AddedPHARVARIS N V+62,628+64.0%+$2.2M
69 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedSPYRE THERAPEUTICS INC-68,457-46.8%$-6.1M
Sold outTERNS PHARMACEUTICALS INC-114,307-100.0%$-6.0M
Sold outNUVALENT INC-56,602-100.0%$-5.8M
Sold outSOLENO THERAPEUTICS INC-165,227-100.0%$-5.5M
ReducedORUKA THERAPEUTICS INC-37,009-46.9%$-3.5M
Sold outAPOGEE THERAPEUTICS INC-35,761-100.0%$-3.0M
ReducedMICRON TECHNOLOGY INC-2,540-66.8%$-2.9M
ReducedBRIDGEBIO PHARMA INC-36,404-73.5%$-2.7M
ReducedAMAZON COM INC-9,000-40.2%$-2.1M
Sold outJAZZ PHARMACEUTICALS PLC-10,838-100.0%$-2.0M
94 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $417.4MQ3 2013: $508.4MQ4 2013: $555.4MQ1 2014: $749.4MQ2 2014: $704.3MQ3 2014: $742.6MQ4 2014: $763.2MQ1 2015: $625.4MQ2 2015: $586.1MQ3 2015: $529.4MQ4 2015: $538.2MQ1 2016: $532.7MQ2 2016: $523.3MQ3 2016: $539.0MQ4 2016: $510.0MQ1 2017: $446.7MQ2 2017: $438.5MQ3 2017: $439.9MQ4 2017: $358.9MQ1 2018: $234.5MQ2 2018: $221.5MQ3 2018: $214.4MQ4 2018: $115.6MQ1 2019: $122.6MQ2 2019: $195.4MQ3 2019: $146.5MQ4 2019: $131.8MQ1 2020: $108.0MQ2 2020: $120.8MQ3 2020: $137.2MQ4 2020: $156.6MQ1 2021: $134.6MQ2 2021: $141.0MQ3 2021: $151.1MQ4 2021: $125.6MQ1 2022: $157.3MQ2 2022: $165.6MQ3 2022: $175.1MQ4 2022: $168.5MQ1 2023: $122.8MQ2 2023: $218.6MQ3 2023: $216.1MQ4 2023: $275.6MQ1 2024: $280.4MQ2 2024: $273.8MQ3 2024: $290.0MQ4 2024: $268.8MQ1 2025: $259.5MQ2 2025: $272.1MQ3 2025: $408.0MQ4 2025: $388.3MQ1 2026: $362.2MQ2 2026: $438.6M
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1INVESCO DB COMMDY INDX TRCKUNIT1,057,238$28.2M6.43%
2ABIVAX SASPONSORED ADS113,031$15.1M3.43%
3REVOLUTION MEDICINES INCCOM66,983$12.5M2.86%
4DEFINIUM THERAPEUTICS INCCOM SHS242,884$11.4M2.60%
5IMMUNOVANT INCCOM277,873$10.7M2.44%
6PRAXIS PRECISION MEDICINES ICOM NEW30,210$10.1M2.31%
7RELAY THERAPEUTICS INCCOM506,235$9.5M2.16%
8ALKERMES PLCSHS179,256$9.4M2.14%
9VAXCYTE INCCOM149,739$8.7M1.98%
10TANGO THERAPEUTICS INCCOM260,070$8.1M1.85%
137 more rows. Subscribe for $29/month to see every row, download the data and use the API.